Admin

Listen on your favorite podcast platform:
Key Points
  • Overview of CAR T cell therapy and its use in hematologic malignancies and solid tumors.

  • Mechanism of action: How CAR T cells are designed to attack cancer cells.

  • Acute side effects: Cytokine release syndrome (CRS) and neurotoxicity, including clinical pearls for treatment.

  • Chronic side effects: Infection monitoring, cytopenias, and risk of secondary malignancies.

  • The role of bridging therapy and tumor burden control prior to CAR T.

  • Guidance for community oncologists on patient care and communication with CAR T centers.

Dr.  Surbhi Sidana

Dr. Surbhi Sidana

Stanford Health Care

Dr. Jason Westin

Dr. Jason Westin

University of Texas